BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1186 related articles for article (PubMed ID: 19874354)

  • 1. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
    Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain.
    Zalacain A; Obrador C; Martinez JP; Viñas M; Vinuesa T
    Med Mycol; 2011 Jul; 49(5):495-9. PubMed ID: 21142899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
    Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Gupta AK; Kohli Y; Batra R
    Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
    Hazen KC
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection.
    Ataides FS; Chaul MH; El Essal FE; Costa CR; Souza LK; Fernandes OF; Silva MR
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1479-85. PubMed ID: 22049990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
    Spader TB; Venturini TP; Rossato L; Denardi LB; Cavalheiro PB; Botton SA; Santurio JM; Alves SH
    Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
    Wildfeuer A; Seidl HP; Paule I; Haberreiter A
    Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
    Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI
    Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method.
    Perea S; Fothergill AW; Sutton DA; Rinaldi MG
    J Clin Microbiol; 2001 Jan; 39(1):385-8. PubMed ID: 11136808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.